CureVac (CVAC) Earnings Date & Reports

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

CVAC is expected to report earnings to -16 cents per share on May 21

Q1'25

Est.

$-0.16

Q4'24

Beat

by $0.09

Q3'24

Beat

by $0.10

Q2'24

Missed

by $0.04

Q1'24

Est.

$-0.31

The last earnings report on April 10 showed earnings per share of -15 cents, beating the estimate of -24 cents. With 350.70K shares outstanding, the current market capitalization sits at 734.01M.

View a ticker or compare two or three

Compare

CVAC